Bionomics Limited Rings the Nasdaq Stock Market Closing Bell

Bionomics Limited (Nasdaq: BNOX), a clinical-stage biopharmaceutical developing novel, allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system disorders with high unmet medical need, rings the Nasdaq Closing Bell remotely from across the globe. Dr Errol De Souza, Executive Chairman, rings the Closing Bell alongside the Company’s team in a virtual bell ringing ceremony.